Computational investigation into Nirematrelvir/Ritonavir synergetic efficiency compared with some approved antiviral drugs targeting main protease (Mpro) SARS-CoV-2 Omicron variant

Although the severity of the spread of corona virus has recently decreased. On this day, there is no available effective medication established to treat COVID-19. Combination drug therapy has been recently gained new momentum as an important platform to design and develop several anti-infective agen...

Full description

Saved in:
Bibliographic Details
Published inJournal of the Indian Chemical Society Vol. 100; no. 3; p. 100891
Main Authors Makhloufi, Abdesselam, Ghemit, Rima, El Kolli, Meriem, Baitiche, Milad
Format Journal Article
LanguageEnglish
Published Elsevier B.V 01.03.2023
Subjects
Online AccessGet full text

Cover

Loading…